Targeting Metallo-β-Lactamase Endemicity: Activity of Novel Meropenem-pilabactam in Combination with Aztreonam Against Contemporary Enterobacterales

Apr 27, 2026

Lucia Maccari, Mariano Echegorry, Diego Faccone, Juan De Mendieta, Melina Rapoport, Celeste Lucero, Ezequiel Albornoz, Paola Ceriana, Alejandra Corso, Fernando Pasteran

In Vitro Activity of Meropenem-pilabactam and Comparators Against Carbapenem-Resistant Acinetobacter Clinical Isolates: Implications for Low- and Middle-Income Countries (LMIC)

Apr 27, 2026

Lucia Maccari, Mariano Echegorry, Miguel Dumas, María Teresita Soto, María José Cima Clave, Ezequiel Albornoz, Paola Ceriana, Alejandra Menocal, Alejandra Corso, Fernando Pasteran

Meropenem-pilabactam (ANT3310): A Novel Agent Targeting Serine Carbapenemase-Producing Enterobacterales

Apr 27, 2026

M. Echegorry, L. Maccari, P. Ceriana, M Rapoport, C. Lucero, MA Menocal, A. Corso, F. Pasteran

High-Potency of the Novel Therapeutic Combination Meropenem/Pilabactam (Formerly Meropenem/ANT3310) Against KPC β-Lactamase Variants Driving Resistance to Ceftazidime/Avibactam

Apr 27, 2026

Salud Rodríguez-Pallares, Lucía Sánchez-Peña, Cristina Elías-López, Roberto Rilo-Antelo, Tania Blanco-Martín, Gloria Pérez-Rodríguez, Lucía González Pinto, Agustina Llanos, Alejandro Beceiro, Germán Bou, Jorge Arca-Suárez​

​Pharmacokinetics-Pharmacodynamics of ANT3310, in Combination with Meropenem, Against Carbapenem-Resistant Acinetobacter baumannii Using a Neutropenic Murine-Pneumonia Model​

Apr 27, 2026

B.D. VanScoy, A.N. Seyfried, M. Nasman, A.S. MacGregor, D. Gillman, C.M. Rubino, S.M. Bhavnani, M. Zalacain, J. Dao, R. Pypstra, P.G. Ambrose